Comparative efficacy of tislelizumab plus lenvatinib and tislelizumab alone against advanced hepatocellular carcinoma after lenvatinib failure: a real-world study.

Saved in:
Bibliographic Details
Title: Comparative efficacy of tislelizumab plus lenvatinib and tislelizumab alone against advanced hepatocellular carcinoma after lenvatinib failure: a real-world study.
Authors: Yang, Jiajin1 (AUTHOR), Xu, Qiuping1 (AUTHOR), Luo, Sihao1 (AUTHOR), Wu, Jianbing2 (AUTHOR) hhgwjb@163.com
Source: BMC Cancer. 4/16/2025, Vol. 25 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-025-14092-1